STOCK TITAN

[SCHEDULE 13G/A] Illumina Inc SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Capital World Investors filed an amended Schedule 13G reporting beneficial ownership of 16,866,776 Illumina shares, representing 10.7% of the 158,300,000 shares believed to be outstanding. CWI reports sole voting power over 16,802,393 shares and sole dispositive power over 16,866,776 shares, and identifies itself as a division of Capital Research and Management Company. The filing states the securities were acquired and are held in the ordinary course of business and were not acquired to change or influence control of Illumina. The filing includes the issuer address, filer address, and CUSIP 452327109.

Capital World Investors ha presentato un emendamento al Schedule 13G dichiarando la proprietà beneficiaria di 16.866.776 azioni Illumina, pari al 10,7% delle 158.300.000 azioni ritenute in circolazione. CWI dichiara di avere il potere di voto esclusivo su 16.802.393 azioni e il potere di disposizione esclusivo su 16.866.776 azioni, e si identifica come divisione di Capital Research and Management Company. Il deposito indica che i titoli sono stati acquisiti e sono detenuti nell'ordinario corso dell'attività e non sono stati comprati per modificare o influenzare il controllo di Illumina. Il documento riporta l'indirizzo dell'emittente, l'indirizzo del dichiarante e il CUSIP 452327109.

Capital World Investors presentó un Schedule 13G enmendado informando la propiedad beneficiaria de 16.866.776 acciones de Illumina, que representan el 10,7% de las 158.300.000 acciones consideradas en circulación. CWI declara tener el poder de voto exclusivo sobre 16.802.393 acciones y el poder de disposición exclusivo sobre 16.866.776 acciones, y se identifica como una división de Capital Research and Management Company. La presentación indica que los valores fueron adquiridos y se mantienen en el curso ordinario del negocio y no se adquirieron para cambiar o influir en el control de Illumina. El documento incluye la dirección del emisor, la dirección del presentador y el CUSIP 452327109.

Capital World Investors는 Schedule 13G 수정본을 제출하여 16,866,776주의 Illumina 주식에 대한 실질적 보유를 보고했으며, 이는 발행주식수로 추정되는 158,300,000주10.7%에 해당합니다. CWI는 16,802,393주에 대한 단독 의결권16,866,776주에 대한 단독 처분권을 보유하고 있으며 자신을 Capital Research and Management Company의 한 부문으로 밝히고 있습니다. 제출서류에는 해당 증권이 통상적인 영업 과정에서 취득·보유된 것이며 Illumina의 지배권을 변경하거나 영향을 미치기 위해 취득된 것은 아니라는 내용이 기재되어 있습니다. 문서에는 발행인 주소, 제출자 주소 및 CUSIP 452327109가 포함되어 있습니다.

Capital World Investors a déposé un Schedule 13G modifié déclarant la propriété bénéficiaire de 16 866 776 actions Illumina, représentant 10,7 % des 158 300 000 actions estimées en circulation. CWI indique détenir le pouvoir de vote exclusif sur 16 802 393 actions et le pouvoir de disposition exclusif sur 16 866 776 actions, et s'identifie comme une division de Capital Research and Management Company. Le dépôt précise que les titres ont été acquis et sont détenus dans le cadre normal des activités et n'ont pas été acquis dans le but de modifier ou d'influencer le contrôle d'Illumina. Le dossier inclut l'adresse de l'émetteur, l'adresse du déposant et le CUSIP 452327109.

Capital World Investors reichte eine berichtigte Schedule 13G ein und meldete die wirtschaftliche Eigentümerschaft von 16.866.776 Illumina-Aktien, was 10,7% der geschätzten 158.300.000 ausstehenden Aktien entspricht. CWI gibt an, über einzelne Stimmrechte für 16.802.393 Aktien und alleinige Verfügungsrechte über 16.866.776 Aktien zu verfügen und bezeichnet sich als Division der Capital Research and Management Company. In der Einreichung heißt es, die Wertpapiere seien im normalen Geschäftsverlauf erworben und gehalten worden und nicht dazu bestimmt, die Kontrolle über Illumina zu ändern oder zu beeinflussen. Die Einreichung enthält die Adresse des Emittenten, die Adresse des Einreichenden und die CUSIP 452327109.

Positive
  • Beneficial ownership of 16,866,776 shares representing 10.7% of the class, a material disclosure above the 5% threshold
  • Sole voting power of 16,802,393 shares and sole dispositive power of 16,866,776 clearly enumerated
  • Filing classifies holdings as ordinary-course, passive ownership under Schedule 13G rather than an active intent to influence control
Negative
  • None.

Insights

TL;DR: Capital World Investors holds a material 10.7% position in Illumina, disclosed as passive ownership.

The filing documents a sizeable holding of 16,866,776 shares (10.7%), which is material to holders given the total outstanding is stated as 158.3 million. The breakdown between voting and dispositive power shows near-complete control by CWI over votes and dispositions reported, which is relevant for shareholder vote math and potential market liquidity. The statement that the position is held in the ordinary course and not for influencing control signals passive intent under Schedule 13G rather than activist intent under Schedule 13D.

TL;DR: Schedule 13G classification and certification point to passive ownership with no declared plan to influence control.

The filer certifies that the shares were not acquired to change or influence issuer control and were acquired in the ordinary course of business. That classification affects disclosure obligations and suggests CWI does not intend to pursue governance actions based on this filing. Investors should note the exact voting and dispositive numbers reported: 16,802,393 sole voting power and 16,866,776 sole dispositive power, which clarify the filers functional authorities over the position.

Capital World Investors ha presentato un emendamento al Schedule 13G dichiarando la proprietà beneficiaria di 16.866.776 azioni Illumina, pari al 10,7% delle 158.300.000 azioni ritenute in circolazione. CWI dichiara di avere il potere di voto esclusivo su 16.802.393 azioni e il potere di disposizione esclusivo su 16.866.776 azioni, e si identifica come divisione di Capital Research and Management Company. Il deposito indica che i titoli sono stati acquisiti e sono detenuti nell'ordinario corso dell'attività e non sono stati comprati per modificare o influenzare il controllo di Illumina. Il documento riporta l'indirizzo dell'emittente, l'indirizzo del dichiarante e il CUSIP 452327109.

Capital World Investors presentó un Schedule 13G enmendado informando la propiedad beneficiaria de 16.866.776 acciones de Illumina, que representan el 10,7% de las 158.300.000 acciones consideradas en circulación. CWI declara tener el poder de voto exclusivo sobre 16.802.393 acciones y el poder de disposición exclusivo sobre 16.866.776 acciones, y se identifica como una división de Capital Research and Management Company. La presentación indica que los valores fueron adquiridos y se mantienen en el curso ordinario del negocio y no se adquirieron para cambiar o influir en el control de Illumina. El documento incluye la dirección del emisor, la dirección del presentador y el CUSIP 452327109.

Capital World Investors는 Schedule 13G 수정본을 제출하여 16,866,776주의 Illumina 주식에 대한 실질적 보유를 보고했으며, 이는 발행주식수로 추정되는 158,300,000주10.7%에 해당합니다. CWI는 16,802,393주에 대한 단독 의결권16,866,776주에 대한 단독 처분권을 보유하고 있으며 자신을 Capital Research and Management Company의 한 부문으로 밝히고 있습니다. 제출서류에는 해당 증권이 통상적인 영업 과정에서 취득·보유된 것이며 Illumina의 지배권을 변경하거나 영향을 미치기 위해 취득된 것은 아니라는 내용이 기재되어 있습니다. 문서에는 발행인 주소, 제출자 주소 및 CUSIP 452327109가 포함되어 있습니다.

Capital World Investors a déposé un Schedule 13G modifié déclarant la propriété bénéficiaire de 16 866 776 actions Illumina, représentant 10,7 % des 158 300 000 actions estimées en circulation. CWI indique détenir le pouvoir de vote exclusif sur 16 802 393 actions et le pouvoir de disposition exclusif sur 16 866 776 actions, et s'identifie comme une division de Capital Research and Management Company. Le dépôt précise que les titres ont été acquis et sont détenus dans le cadre normal des activités et n'ont pas été acquis dans le but de modifier ou d'influencer le contrôle d'Illumina. Le dossier inclut l'adresse de l'émetteur, l'adresse du déposant et le CUSIP 452327109.

Capital World Investors reichte eine berichtigte Schedule 13G ein und meldete die wirtschaftliche Eigentümerschaft von 16.866.776 Illumina-Aktien, was 10,7% der geschätzten 158.300.000 ausstehenden Aktien entspricht. CWI gibt an, über einzelne Stimmrechte für 16.802.393 Aktien und alleinige Verfügungsrechte über 16.866.776 Aktien zu verfügen und bezeichnet sich als Division der Capital Research and Management Company. In der Einreichung heißt es, die Wertpapiere seien im normalen Geschäftsverlauf erworben und gehalten worden und nicht dazu bestimmt, die Kontrolle über Illumina zu ändern oder zu beeinflussen. Die Einreichung enthält die Adresse des Emittenten, die Adresse des Einreichenden und die CUSIP 452327109.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Capital World Investors
Signature:Timothy J. Moon
Name/Title:Vice President and Senior Counsel, Capital Research and Management Company
Date:08/04/2025

FAQ

How many Illumina (ILMN) shares does Capital World Investors own?

Capital World Investors reports beneficial ownership of 16,866,776 shares of Illumina common stock.

What percentage of ILMN does Capital World Investors hold?

The filing states this holding represents 10.7% of the shares believed outstanding (158,300,000 shares).

How much voting power does Capital World Investors report for ILMN?

CWI reports sole voting power over 16,802,393 shares and no shared voting power.

Was the ILMN position filed as passive or activist?

The Schedule 13G certifies the securities were acquired and are held in the ordinary course of business and were not acquired to change or influence control, indicating passive intent.

What identifying details are included in the filing for ILMN?

The filing provides issuer address (5200 Illumina Way, San Diego, CA), filer address (333 South Hope Street, Los Angeles), and CUSIP 452327109.
Illumina Inc

NASDAQ:ILMN

ILMN Rankings

ILMN Latest News

ILMN Latest SEC Filings

ILMN Stock Data

16.01B
153.38M
0.18%
101.5%
4.99%
Diagnostics & Research
Laboratory Analytical Instruments
Link
United States
SAN DIEGO